Mountain Valley MD appoints chief medical officer

• Mountain Valley MD (OTCQB:MVMDF) appoints Dr. Azhar Rana as the company’s Chief Medical Officer.
• Dr. Rana brings to the company nearly two decades of life sciences experience in clinical development, pre and post launch medical affairs, regulatory and commercial strategy, including 10 years of pharmaceutical leadership at Bristol Myers-Squibb, Novo Nordisk and AstraZeneca.
• The company has granted 1M options to Dr. Rana at an exercise price of $0.365 per share. The options are exercisable for a period of five years, 20% vesting on the date of grant, 30% on the 6-month anniversary following the date of grant and the remaining 50% on the 12-month anniversary following the date of grant.